RSS feed

Publications by Egil Røsjø

10 publications found

Original articles

Røsjø E, Lindstrøm JC, Holmøy T, Myhr KM, Varhaug KN, Torkildsen Ø (2020)
Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
Front Neurol, 11, 329
DOI 10.3389/fneur.2020.00329, PubMed 32425877

Holmøy T, Røsjø E, Zetterberg H, Blennow K, Lindstrøm JC, Steffensen LH, Kampman MT (2018)
Vitamin D supplementation and neurofilament light chain in multiple sclerosis
Acta Neurol Scand, 139 (2), 172-176
DOI 10.1111/ane.13037, PubMed 30317548

Lossius A, Tomescu-Baciu A, Holmøy T, Vedeler CA, Røsjø E, Lorentzen ÅR, Casetta I, Vartdal F (2017)
Selective intrathecal enrichment of G1m1-positive B cells in multiple sclerosis
Ann Clin Transl Neurol, 4 (10), 756-761
DOI 10.1002/acn3.451, PubMed 29046884

Holmøy T, Beiske AG, Zarnovicky S, Myro AZ, Røsjø E, Kerty E (2016)
Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report
BMC Neurol, 16 (1), 197
DOI 10.1186/s12883-016-0720-2, PubMed 27756254

Røsjø E, Lossius A, Abdelmagid N, Lindstrøm JC, Kampman MT, Jørgensen L, Sundström P, Olsson T, Steffensen LH, Torkildsen Ø, Holmøy T (2016)
Effect of high-dose vitamin D₃ supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis
Mult Scler, 23 (3), 395-402
DOI 10.1177/1352458516654310, PubMed 27325604

Røsjø E, Steffensen LH, Jørgensen L, Lindstrøm JC, Šaltytė Benth J, Michelsen AE, Aukrust P, Ueland T, Kampman MT, Torkildsen Ø, Holmøy T (2015)
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis
J Neurol, 262 (12), 2713-21
DOI 10.1007/s00415-015-7902-5, PubMed 26429571

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Šaltytė Benth J, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T (2015)
Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis
J Neuroimmunol, 280, 21-8
DOI 10.1016/j.jneuroim.2015.02.001, PubMed 25773151

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T (2014)
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis
J Neuroimmunol, 271 (1-2), 60-5
DOI 10.1016/j.jneuroim.2014.03.014, PubMed 24713402

Corthay A, Skovseth DK, Lundin KU, Røsjø E, Omholt H, Hofgaard PO, Haraldsen G, Bogen B (2005)
Primary antitumor immune response mediated by CD4+ T cells
Immunity, 22 (3), 371-83
DOI 10.1016/j.immuni.2005.02.003, PubMed 15780993

Review articles

Bogen B, Ruffini PA, Corthay A, Fredriksen AB, Frøyland M, Lundin K, Røsjø E, Thompson K, Massaia M (2006)
Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research
Haematologica, 91 (7), 941-8
PubMed 16818282